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Background: Massive implementation of malaria diagnostics in low-resource countries is regarded as a pivotal
strategy in control and elimination efforts. Although malaria rapid diagnostic tests (RDTs) are considered a viable
alternative, there are still obstacles to the widespread implementation of this strategy, such as reporting constraints
and lack of proper quality assurance of RDT-based programmes at point-of-care (POC).
Methods: A prospective cohort of patients, seeking routine care for febrile episodes at health centres in
malaria-endemic areas of Colombia, was used to assess the diagnostic performance of a device based on
smartphone technology (Deki ReaderTM, former codename “GenZero”), that assists users at POC to process RDTs.
After informed consent, patients were enrolled into the study and blood samples were collected for thick blood
smear (TBS) and RDT. The RDT results were interpreted by both visual inspection and Deki Reader device and
concordance between visual and device interpretation was measured. Microscopy corrected by real-time polymerase
chain reaction (PCR) and microscopy were “gold standard” tests to assess the diagnostic performance.
Results: In total, 1,807 patients were enrolled at seven health centres in malaria-endemic areas of Colombia.
Thirty-three Plasmodium falciparum and 100 Plasmodium vivax cases were positive by corrected microscopy.
Both sensitivity and specificity were 93.9% (95% CI 69.7-95.2) and 98.7% (95% CI 98.5-99.4) for P. falciparum, and
98.0% (95% CI 90.3-98.9) and 97.9% (95% CI 97.1-98.5) for P. vivax. Percentage concordance between visual and
device interpretation of RDT was 98.5% and 99.0% for P. vivax and P. falciparum, respectively.The RDT, when
compared to TBS, showed high sensitivity and specificity for P. falciparum in both visual and device interpretation,
and good overall diagnostic performance for P. vivax. Comparison between PCR as gold standard and visual and
device interpretation showed acceptable overall performance for both species.
Conclusions: The diagnostic performance of the Deki Reader was comparable to visual interpretation of RDTs
(without significant differences) for both malaria species. Providing standardized automated interpretation of RDTs
at POC in remote areas, in addition to almost real-time reporting of cases and enabling quality control would
greatly benefit large-scale implementation of RDT-based malaria diagnostic programmes.
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Malaria is transmitted in about 106 countries in tropical
and subtropical regions where ~3.3 billion people, half of
the world’s population, are at risk of malaria transmission.
The World Health Organization (WHO) estimates that over
219 million cases (uncertainty range of 154 to 289 million)
and about 660,000 malaria deaths (uncertainty range
of 490,000 to 836,000) occur worldwide every year [1],
representing an enormous global social and economic
burden. Clinical manifestations of the disease are similar to
many other infectious diseases making clinical diagnosis
alone imprecise and inaccurate. Confirmation of malaria,
which depends on the detection of Plasmodium parasites
in blood circulation, is not only critical for appropriate
case management [2], but it is essential for epidemiological
purposes and to enhance malaria control programmes.
Microscopic detection of Plasmodium species on thick
blood smear (TBS) has been for decades the standard
method for malaria diagnosis despite its field accuracy,
errors in species identification and its operator-dependence.
Although it is less expensive and easier to handle than
other malaria diagnostic methods developed more re-
cently, it is laborious and time consuming, and it requires
electricity as well trained personnel, frequently not avail-
able in remote malaria-endemic areas. Recently, a number
of techniques aimed at reducing the time of processing
and some other constraints of TBS have been developed.
Some of them include fluorescence stains but still require
microscopes, others are based on detection of parasite
nucleic acids in human blood circulation but require
expensive and complex equipment, and others are based
on the use of antibodies that recognize parasite compo-
nents [3,4]. The methods based on parasite nucleic acid
detection, have proven great sensitivity and specificity,
however, they require significant infrastructure and train-
ing, and are significantly more expensive than TBS, there-
fore precluding expanded implementation in low-resource
settings [5]. Attempts to simplify these methods are
currently underway based on loop-mediated isothermal
amplification (LAMP) which requires less sophisticated
equipment, such as a water bath and ultraviolet light,
which could be installed in more underserved regions, but
still requires electricity [6].
Malaria diagnostic methods based on the use of monoclo-
nal antibodies recognizing parasite antigens [3,4] have been
grouped under the name of malaria rapid diagnostic tests
(RDT). These methods have shown great performance in
term of sensitivity and specificity, although they still present
limitations, such as batch-to-batch variation, and limited
sensitivity at low parasitaemia levels (<0.1%). Although these
RDTs still require improvement, their apparent simplicity
currently makes them attractive to provide diagnosis at all
levels of the health care system, particularly in remote areas
where health workers have limited supervision and training.The reliability of RDT results is pivotal to ensure the
safety of withholding anti-malarial treatment in test-
negative patients [7-10]. As recommended by WHO,
the possibility of diagnosis error using RDTs can be
minimized through a careful selection process [11]. Import-
ant steps involved in the process of ensuring high quality of
RDTs include among others, high diagnostic perform-
ance as assessed in product testing by the WHO and
the Foundation for Innovative New Diagnostics (FIND)
[12], proper storage of the test kits, adequate labelling,
clear operation instructions, continuous on-the-job training
(job aids), and automated interpretation to avoid inter-user
variability. In addition, implementation of large-scale diag-
nostic programmes based on malaria RDTs requires the
establishment of a comprehensive quality assurance (QA)
strategy. This task can be particularly challenging consider-
ing that most RDTs are being used at point-of-care (POC)
in health centres and dispensaries located in remote areas.
The performance of health professionals using RDTs
can be improved through simple redesign of job aids
[7,8,13,14], as well as by QA programmes based on
supervisory visits to assess their competence to correctly
use and interpret RDTs results [15]. However, the sustain-
ability of this type of QA programme is highly question-
able due to costs of personnel, transportation and other
expenses [16,17]. Currently available technologies such as
cell-phone networks, could reduce costs and increase the
efficiency as a supervisor could conduct QA activities
to multiple facilities without the need to visit the sites,
as shown in preliminary studies with both malaria and
HIV RDT programmes [18-20].
The present report describes a field trial in malaria-
endemic areas of Colombia of a system that includes
mobile, battery-operated devices based on smartphone
technology that assists users at POC to process RDTs,
performing automated interpretation, reducing notification
time to a cloud-based database and allowing malaria case
geo-location and remote QA activities. The main objective
of the trial was to assess the concordance between auto-
mated interpretation of RDTs by the device and by visual
inspection by laboratory experts.
Methods
Study design and study sites
The present study involved a prospective cohort of con-
secutive patients from August 2011 to January 2012 at
seven sites in four towns located in malaria-endemic areas
of Colombia (Figure 1): Tumaco and Buenaventura in the
Pacific coast, and Monteria and Tierralta in the north-
western department of Córdoba. These four sites were se-
lected based on their high malaria incidence and their reli-
able mobile phone connectivity. Patients were recruited at
the main governmental malaria diagnosis facility, regional
hospitals and Public Health Laboratory and at a diagnostic
Figure 1 Geographical location of sites participating in the field study.
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(Caucaseco). Tumaco, is a municipality situated close
to the border with Ecuador, in the southwest area of
Colombia with a population of 100,000 inhabitants and
with Plasmodium falciparum as predominant parasite
species. Buenaventura is the main port of Colombia on the
Pacific coast with a population of ~360,000 habitants, with
similar prevalence of both P. falciparum and Plasmodium
vivax infections. Monteria is the political capital of the
department of Córdoba, with a population of ~300,000
inhabitants and Tierralta, a town located about 100 km
south of Monteria, with a population of ~80,000, with
predominance of P. vivax infections. Patients were mostly
Afro-descendants of both genders, seeking routine care forfebrile episodes and were enrolled into the study after sign-
ing an informed consent form. Before the conduct of the
trial, the protocol was reviewed and approved by the insti-
tutional ethics committee (CECIV, May 2011, Code 008).
Study population
Eligible participants were consecutively enrolled in the
dispensaries and at the outpatient clinics of the institu-
tions described above. Inclusion criteria were age ≥ one
year, a documented fever or a history of fever in the pre-
vious 48 hours and a written informed assent/consent to
participate in the study. No information regarding recent
use of anti-malarials was collected. Study technicians en-
rolled study participants and collected demographic and
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structured form. After enrolment, blood was collected
once from a finger prick (no follow-ups) and about three
to four blood drops were used for preparation of TBS,
RDTs, and a filter-paper blood spot for real-time poly-
merase chain reaction (PCR). The latter was performed
as quality control of microscopy. Technicians working at
the reference laboratory were blinded to results of both
visual and device interpretation of RDTs performed at
the site. Likewise, results of TBS microscopy examination
and PCR (when applicable) were blinded to site technician
who performed the RDTs. The processing of the RDT was
performed according to manufacturer recommendations
and guided by a job aid displayed on the screen of the
Deki Reader device (former codename “GenZero”). The
device also assisted technicians at the sites in keeping
track of the incubation time for each RDT processed.
Once the incubation period was completed, the study
technician interpreted the RDT by visual inspection of the
strip and captured the result using the touch-screen of the
device. The study technician then immediately inserted
the cassette into the device to perform the automated in-
terpretation of the test. The results of the device’s inter-
pretation of the RDT were concealed at all times, and
were generated in all cases after the study site technician
had entered results of her/his visual interpretation of RDT
test results. All results of RDTs interpretation, along with
a high-resolution image of the RDT captured by the device,
and the patient data collected were encrypted and automat-
ically transmitted to a central cloud database specifically
designed for the purpose of the trial. Patient management
was performed according to official protocols of the
national malaria control programme [21], based on the
results of TBS microscopic examination.
Laboratory analyses and device procedures
Microscopic diagnosis
Symptomatic patients were bled by finger prick and
TBS were prepared and stained using the standard 10%
Giemsa method [22]. Slides were examined under high
power objective and asexual parasites were counted against
200 white blood cells (WBCs). Smears were considered
negative if the examination of 200 high power fields did
not reveal asexual parasites.
Malaria RDTs
The malaria RDT used in the current study was SD Bioline
Malaria Antigen Pf/Pv (Catalogue No. 05FK80, Standard
Diagnostics Inc., Hagal-Dong, Korea), referred here to
as RDT. This is a lateral flow immunochromatographic
test that contains a membrane strip encased in a flat plas-
tic cassette. The strip is pre-coated with two monoclonal
antibodies: one specific for P. falciparum HRP2 protein
and the other one specific for P. vivax pLDH enzyme.Interpretation of the results was based first on the
presence of the control line, and then on the presence
of one or two lines.
PCR correction
PCR was adapted from Rougemont et al. [23], and per-
formed in all cases of discrepant results between expert
visual interpretation of RDT, device’s interpretation of
RDT and expert microscopy results (tie-breaker). Genomic
DNA was extracted from dried filter paper spots using
Chelex-resin (Biorad, Hercules, CA, USA) according to
the method of Wooden et al. [24]. PCR was performed
using the same set of primers and species-specific
probes (Applied Biosystems, USA), with reporters and
quenchers adapted to the dye channels of ABI7500 device
(Applied Biosystems, USA). Duplex PCR reactions were run
in parallel to detect P. falciparum and P. vivax, the 20 μl
reaction mix contained 2 μl DNA, 1× TaqMan Master Mix
(Applied Biosystems, USA), 200 nM forward and reverse
primer, 200 nM P. falciparum probe and 100 nM P. vivax
probe. The PCR programme consisted of an initial step of
10 min at 95°C followed by 40 cycles of 10 sec at 95°C and
finally 60 sec at 60°C. Each experiment included the test
sample in duplicate, non-infected DNA as negative control
and a positive control with a known parasitaemia for P.
vivax and P. falciparum. Parasitaemia was calculated using
an average standard curve of pre-determined parasitaemia.
The detection limit calculated was one parasite/ml based on
the upper limit of the calibration curve at the lowest de-
tected concentration. In addition, PCR was performed in a
randomly selected subset of samples, and used in an ad hoc
analysis with PCR results as gold standard (n = 274).
The Deki Reader™ (formerly known with
codename “GenZero”)
This is a mobile, ruggedized, battery-operated device
(Figure 2), manufactured by Fio Corporation, (Toronto,
Canada), designed to perform the following functions:
1) automated interpretation of RDTs by means of image
analysis software; 2) digital data capture, by means of a
touch-screen and a simple user interface software; and,
3) transmission in real-time (RT) of all data to an access-
ible central database, using local mobile phone network.
Transmitted data included: processed RDT image, diag-
nostic event data collected, user and device interpretation
of test results, geo-positioning of the device, and date and
time stamp. The principal investigator (PI) and study co-
ordinators had permanent access to the database via the
internet portal especially designed for the study.
Training on the operation of Deki Reader
Seven laboratory microbiologists with five years of uni-
versity education and former training on malaria micros-
copy were engaged to operate the Deki Reader and to fill
Figure 2 Deki Reader device.
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tory personnel were trained in a two-day workshop on all
study procedures, the operation of RDTs assembled to
a Deki Reader, as well as on the collection of patients’
information, including the informed consent form.
Statistical methods
The prevalence of malaria cases (P. falciparum and P. vivax)
at the study areas was estimated to be 10 to 15%, P. vivax
being responsible for ≥75% of the malaria cases. Based
on this prevalence, the sample size was estimated to be
between 1,800 to 2,000 subjects, under the assumption
that it would provide approximately 120 to 225 posi-
tive results for P. vivax and 40 to 75 positive results for
P. falciparum. Assuming that the sensitivity and speci-
ficity of the interpretation of RDT is the same as the
human-eye interpretation, this sample size would provide
95% confidence intervals within 5% of the point estimate.
Results of RDT were interpreted by both visual examin-
ation and by the Deki Reader device.
Data were obtained from the source documents at each
of the participant malaria sites and was compared with the
information collected through devices and transmitted
to the cloud database. Data collected were monitored
according to U S Food and Drug Administration (FDA)
regulations and Good Clinical Practice (GCP) guidelines.
There were three outcomes of interest for the purpose
of the analysis in the current trial: a) microscopy results:
performed on TBS by laboratory technician at reference
laboratory and entered manually into the dataset; b) visual
interpretation of RDT: performed by laboratory technician
at the site following visual inspection of the RDT at theappropriate time, and entered into the Deki Reader device;
and, c) device interpretation of RDT: performed by the
device, which was automatically collected and transmitted
to the database by the device. Data collected at the cloud
database were reconciled to data collected in the internal
memory card of each Deki Reader device to ensure that
all data points were correctly transmitted to the cloud
database. Data analysis was performed using JMP Version
8.0.2 and R Version 2.12.1 (SAS Institute Inc. NC, USA).
The primary analysis was conducted using microscopy
corrected by PCR as gold standard to determine diagnostic
performance characteristics [25,26] (sensitivity, specificity,
negative (NPV) and positive (PPV) predictive values, and
overall diagnostic accuracy) of RDT interpretation by the
Deki Reader and by visual interpretation. Secondly, micros-
copy and PCR were used as gold standards. Correspondent
95% confidence intervals were constructed using the
Wilson score method. The percentage of agreement in
the interpretation of RDTs between the device and visual
(human-eye) done by the expert laboratory technicians at
the sites was calculated as percentage of negative agree-
ment, percentage of positive agreement and overall percent-
age of agreement. Two-sided 95% confidence intervals were
constructed using the Wilson score method. Fisher’s exact
test was used to compare differences between device and
visual interpretation and P value < 0.05 was considered
statistically significant.
Results
Between August 2011 and January 2012, a total of 2,191
subjects were screened. However, the final analysis included
1,807 samples, after 384 (17.5%) were excluded due to lack
Table 1 Demographics of study population










≥ 1 to < 17 341 (18.9%)
≥ 17 to <65 1,380 (76.4%)
≥ 65 70 (3.8%)
Herrera et al. Malaria Journal 2014, 13:87 Page 6 of 10
http://www.malariajournal.com/content/13/1/87of compliance with the protocol: 238 (62%) were sam-
ples collected in a centre where RDT processing was
performed in major violation of RDT manufacturer’s
recommendation; 78 (20%) patient samples due to in-
complete written informed consent process, and 68
(18%) due to RDT processing by non-study authorized
personnel (Figure 3).
The main demographic features of the cohort are de-
scribed in Table 1. The proportion of female participants
was 54.3%, and the population was predominantly adults
(76.4%) between 17 and 65 years of age. The prevalence
of microscopically confirmed malaria cases among
the recruited patients was 7.58% (33 cases of positive
P. falciparum infection and 100 cases of P. vivax). Positive
cases varied among the sites between 1.89 and 5.84% for
P. faciparum, and between 1.52 and 10.54% for P. vivax,
which is in agreement to the local known epidemi-
ology concerning distribution of Plasmodium species
infections [27]. Prevalence of P. falciparum infections
was higher in the sites of Tumaco and Buenaventura
(25 P. falciparum and 30 P. vivax infections), while P. vivax
infection was higher in Tierralta (eight P. falciparum and
70 P. vivax infections).
Of the 2,191 samples, in 37 (1.7%) no primary or sec-
ondary outcomes (regarding results of the interpretation
of RDTs), either visual or by the device were found in
the dataset, most likely due to software malfunction,
and these patients were not included in the analysis.
Therefore, the final analysis dataset consisted of 1,770
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Figure 3 Patient flowchart for Deki Reader RDT results.Comparison between diagnostic performance
characteristics of the visual interpretation and Deki
Reader interpretation of RDTs
The percentage agreement between visual interpretation
and Deki Reader interpretation of RDTs for P. falciparum
was 95.7% (95% CI 85.5-98.8) when a positive result was
obtained, 99.1% (95% CI 98.5-99.4) when a negative re-
sult was obtained, and an overall percentage agreement
of 99.0% (95% CI 98.4-99.4) (Table 2). The percentage
interpretation agreement between the Deki Reader and
visual for P. vivax was 98.9% (95% CI 94.0-99.5), when a
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Table 2 Comparison of performance between Deki
Reader and visual interpretation (n = 1,762) of RDTs









P. falciparum 99.1 (98.5 - 99.4) 95.7 (85.5 - 98.8) 99.0 (98.4 - 99.4)
P. vivax 98.9 (94.0 – 99.5) 99.1 (97.8 - 99.0) 98.5 (97.9 - 99.0)











P.vivax Visual 71.8 97.4 62.7 98.3 0.876
Device 72.1 96.6 56.0 98.3
P.falciparum Visual 35.1 98.4 41.7 97.9 0.843
Device 33.3 98.1 35.9 97.8
*Fisher’s exact test for sensibility.
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agreement of 98.5% (95% CI 97.9-99.0). There was no
statistically significant difference in the sensitivity or in
the specificity between the two methods of interpretation
for any of the Plasmodium species.
Discordant results between Deki Reader and visual
interpretation of RDTs
From a total of 30 discrepant test results, discordant
results were obtained in 26 RDTs (1.47%) for either
P. falciparum or P. vivax results and two showed discord-
ant results for both Plasmodium species. In 28/30 (93%)
discrepant interpretations, the visual inspection failed to
detect a line, but the device reported a “positive” result. In
the remaining two cases, it was the opposite. In ten (33%)
of the 30 discrepant results, a closer review of the images
of the RDTs revealed the presence of artefacts and bizarre
smearing of the test strip that could have caused the soft-
ware in the device to interpret as presence of a line. The
presence of these unusual patterns in the flow of the sample
along the diagnostic strip renders the test inconclusive and
therefore should have resulted in processing a new RDT.
In an additional seven cases, including the two where
the visual inspection reported the presence of a line, the
discrepancy seems to be originated from clerical mistakes
by either registering a negative result when clearly visible
lines were present in the RDT, registering a positive re-
sult when no lines were visible and no parasites were
reported either by microscopy or PCR, or by mistakes
in the identification of the tests. In an additional three
cases, results of microscopy and/or PCR confirmed the
presence of parasites and therefore were true positive cases
(device interpretation was correct). In the remaining ten
cases, all of which the device interpreted as positive with
line intensity values very close to the cut-off value, both
microscopy and PCR failed to detect presence of para-
sites and therefore correspond to false positive results
(0.56%) (device interpretation was incorrect).
Sensitivity and specificity of Deki Reader and visual
interpretation of RDTs
Of the 1,770 samples tested, 94 were positive for
Plasmodium by both diagnostic methods (TBS and RDT),
1,525 were negative by both diagnostic tests and 132
had discordant results. Of these discordant samples, 70(4%) were positive only by RDT, 43 (2%) were positive
only by TBS and 19 (1%) had discordant parasite species
results. This discrepancies were solved using PCR as a
tie-breaker, finding that 24 (34%) of the 70 RDT-positive
samples were positive, 39 (90%) of the 43 TBS-positive
samples were negative and 74% (14/19) the samples with
species discrepancies had PCR results that were in line
with RDT results.
TBS microscopy as gold standard
When standard TBS microscopy results were compared
to interpretation of RDT, the Deki Reader had a sensi-
tivity of 33.3% (95% CI, 21.4-47.6) and a specificity of
98.1% (95% CI 97.3-98.7) for detection of P. falciparum
infections, and sensitivity of 72.1% (95% CI, 62.5-80.5) and
a specificity of 96.5% (95% CI 95.6-97.4) for detection of
P. vivax infections. The correspondent sensitivity of expert
visual interpretation of RDTs was 35.1% (95% CI, 22.9-48.9)
and specificity of 98.4% (95% CI 97.7-98.9) for detection of
P. falciparum infections, and sensitivity of 71.8% (95% CI,
62.1-80.3) and a specificity of 97.4% (95% CI 96.5-98.0) for
detection of P. vivax infections (Table 3).
TBS microscopy corrected by PCR as gold standard
When compared to microscopy corrected by PCR, the
Deki Reader had a sensitivity of 93.9% (95% CI 69.7-95.2)
and a specificity of 98.7% (95% CI 98.5-99.4) for detection
of P. falciparum infections, and sensitivity of 98.0% (95%
CI 90.3-98.9) and a specificity of 97.9% (95% CI 97.1-98.5)
for detection of P. vivax infections (Table 4). The sensitivity
and specificity of expert visual interpretation of RDTs were
identical to the Deki Reader for detection of P. falciparum
infections, and for detection of P. vivax infections the
sensitivity was 87.8% (95% CI 86.4-97.2) and the specificity
99.0% (100% CI 98.0-99.14). Finally, the performance
of microscopy was 60.6% (95% CI 44.9-78.5) and 98.0%
(95% CI 97.3-98.6) for sensitivity and specificity against
P. falciparum; and 75.0% (95% CI 66.0-83.4) and 98.4%
(95% CI, 97.7-99.0) for sensitivity and specificity against
P. vivax (Table 4). The diagnostic performance of visual
and Deki Reader interpretation of RDTs was virtually
identical, and showed a higher sensitivity than microscopy
for both species for all the gold standards used.
Table 4 Deki Reader diagnostic performance against












P. vivax Visual 94.0 98.6 80.5 99.6 0.149
Device 98.0 97.8 73.1 99.8
P. falciparum Visual 87.8 99.0 62.5 99.7 0.392
Device 93.9 98.7 62.5 99.7
*Fisher’s exact test for sensibility.
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When compared to PCR results performed in a subset
of 274 randomly selected samples the performance of
microscopy was 54.6% (95% CI 23.4-83.3) and 98.9%
(95% CI 96.7-99.8) for sensitivity and specificity against
P. falciparum; and 68.0% (95% CI 46.5-85.0) and 98.8%
(95% CI 96.5-99.75) for sensitivity and specificity against
P. vivax (Table 5).
Discussion
Early and adequate malaria diagnosis is critical to opportune
and effective treatment to prevent clinical complications
and death. Among the malaria diagnostic tools currently
available, microscopic examination of TBS remains the gold
standard for defining malaria infection, not only because
of the relative ease and low cost, but also for its ability to
provide a quantitative result. Malaria RDTs are particularly
useful in remote areas of difficult access and lack of
basic infrastructure required in a microscopy post. The
interpretation of two test lines contained in the RDT
may be challenging from the point of view of personnel
with low level of education, training and supervision
(i e, community health workers) located in remote rural
areas. Although the SD Bioline Malaria Antigen Pf/Pv RDT
imposes this difficulty, it was decided to use this RDT in
combination with the Deki Reader due to the known pres-
ence of both parasite species in the study areas. A previous
study conducted in rural health facilities in Tanzania dem-
onstrated that interpretation of SD Bioline Malaria Ag Pf/
Pan RDT by Deki Reader is substantially equivalent to that
of visual interpretation as performed by laboratory techni-
cians with vast experience in RDT processing and interpret-
ation [28], suggesting that a device such as the Deki Reader
can be used in routine care for interpretation of RDT with
high-quality diagnostic results at POC.
In the present study, the performance of the Deki Reader
interpreting SD Bioline Pf/Pv RDTs was at least as good asTable 5 Quality control of microscopy using PCR on a
subset of samples
PCR Sensibility (%) Specificity (%) PPV (%) NPV (%)
P. vivax 68.0 98.8 85.0 96.9
P. falciparum 60.6 98.0 66.7 98.1the visual interpretation by experts, with sensitivity, spe-
cificity, positive and negative predictive value similar to
visual interpretation of the same RDT (Tables 2 and 3).
There was no statistically significant difference between
the diagnostic accuracy of the Deki Reader and the visual
interpretation of RDTs (Fisher’s exact test).
Important differences in the accuracy of the Deki Reader
were identified when microscopy was used as the gold
standard for malaria diagnosis. Most of the RDT-positive/
microscopy-negative discordance is likely due to reduced
specificity as result of the persistent antigenaemia of
P. falciparum for approximately two weeks after parasite
clearance [29] and most of microscopy-positive/RDT-
negative cases might have originated in deficiencies in
the microscopy test.
Similar findings to the present study with respect to
comparative performance of microscopy versus RDTs
have been reported previously [30-35], and the sensitivity
and specificity of the RDTs with this reference test
were in agreement with previous reports, including the
third evaluation round of FIND [12]. In the same way,
other studies using microscopy corrected by PCR suggested
that RDTs may actually be more sensitive than expert slide
reading [36]. However, RDTs are not able to replace
microscopy as the gold standard for malaria diagnosis,
they can be used as complementary technique in situation
where experienced personnel are not available, in order to
perform a rapid diagnosis, which can a few hours later be
confirmed or corrected by microscopy or PCR.
The areas selected for this study, although distant from
main cities of Colombia, benefit from electricity, basic la-
boratory facilities and are reachable by road. They all had
sufficient conditions for proper storage of the test kits. Deki
Reader batteries could be recharged easily when needed
and communication infrastructure for mobile and land
telephone were both available.
TBS microscopy presented serious limitations, with fac-
tors such as variability in techniques of blood film prepar-
ation, staining, reading standards, and most importantly,
highly dependent on the level of expertise of microscopists.
In the present study, laboratory technicians had training
and experience above the standard level of field micro-
scopist. Despite their university training, the significant
loss of information for the final analysis (384 = 17.5%),
most of which (238 = 10.8%) presented major violation
of RDT manufacturer’s recommendation, indicated that
although constant monitoring was available, the two-day
training may have been insufficient. The PI and study coor-
dinators had permanent access to the database via internet
portal especially designed for the study and were able to
monitor the progress of the study and to review images of
the RDTs which allowed them to redirect training efforts to
the areas where images suggested RDT mishandling. Device
users in the field were able to perform the data collection
Herrera et al. Malaria Journal 2014, 13:87 Page 9 of 10
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ation of RDTs without major problems. Likely, due to
software malfunction early in the course of the study,
data from 37 samples (1.7%) were not recorded in the
device nor transmitted to the database.
Although some places in remote endemic regions do
not yet have reliable mobile phone connectivity, the
device saves all data which can be transmitted later
under good connections to mobile networks. The data
and images displayed in the portal created for this study
allowed to follow up closely the performance of field oper-
ators. It has also demonstrated the potential to be greatly
beneficial to health programme managers by providing a
tool to perform remote QA monitoring of field activities.
The ability to assist in POC diagnosis, and simultaneously
capture and make immediately available pivotal epidemio-
logical data at source of origin makes this a very attractive
tool to enhance epidemiological surveillance, strengthen
health care systems, and contribute to global mapping
efforts of malaria and other infectious diseases [37-39].
The information collected, along with the correspondent
RDT image, was sent immediately from remote areas
to a database, being part of the Fio Cloud services with
100% fidelity.
Although the function of the Deki Reader is to interpret
the presence or absence of a test line signal, independent of
the analyses that are finally deposited on it, these results
could not be extrapolated to other RDTs. Important differ-
ences in RDT clinical diagnostic performance have been
well documented, and therefore the results presented here
are only applicable to SD Bioline Malaria Antigen Pf/Pv
RDT. Nevertheless, the performance of the Reader should
be independent to the underlying immunochemistry and
thus should provide similar performance characteristics for
other RDTs using the same immunochromatographic test.Conclusions
The diagnostic performance of the Deki Reader was
comparable to visual interpretation of RDTs (concordance
rate >98%) for both malaria species. Providing stan-
dardized automated interpretation of RDTs at POC in
remote areas, in addition to almost real-time reporting
of cases and enabling quality control would greatly
benefit large-scale implementation of RDT-based malaria
diagnostic programmes.
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